| NCT03216564 |
An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT03216564 |
Recruiting |
Hamad Medical Corporation |
2019-05-10 |
| NCT03824379 |
Magnesium Supplementation in Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT03824379 |
Recruiting |
Ain Shams University |
2020-03-01 |
| NCT03344549 |
Effect of the Teleconsultation of Renal Nutrition on Renal Function and Glycemic Control in Patients With DKD |
https://ClinicalTrials.gov/show/NCT03344549 |
Completed |
Hospital Civil Juan I. Menchaca |
2019-02-05 |
| NCT03325322 |
Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease |
https://ClinicalTrials.gov/show/NCT03325322 |
Recruiting |
Mayo Clinic |
2023-01-31 |
| NCT03217591 |
A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria |
https://ClinicalTrials.gov/show/NCT03217591 |
Completed |
Cyclerion Therapeutics |
2019-08-20 |
| NCT03184662 |
Efficacy of a High-intensity Physical Activity Program on Renal Function in High Risk Patients With Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT03184662 |
Recruiting |
Poitiers University Hospital |
2022-07-31 |
| NCT03174821 |
Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT03174821 |
Completed |
Chinese PLA General Hospital |
2014-05-16 |
| NCT03165227 |
This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses) |
https://ClinicalTrials.gov/show/NCT03165227 |
Completed |
Boehringer Ingelheim |
2019-12-10 |
| NCT03164785 |
Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT03164785 |
Recruiting |
Second Xiangya Hospital of Central South University |
2018-12-31 |
| NCT03147677 |
Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan |
https://ClinicalTrials.gov/show/NCT03147677 |
Completed |
The Third Xiangya Hospital of Central South University |
2018-07-30 |
| NCT03105219 |
IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart Disease |
https://ClinicalTrials.gov/show/NCT03105219 |
Recruiting |
Nanjing First Hospital, Nanjing Medical University |
2021-05-30 |
| NCT03078101 |
EMPRA (EMPagliflozin and RAs in Kidney Disease) |
https://ClinicalTrials.gov/show/NCT03078101 |
Completed |
Medical University of Vienna |
2019-06-18 |
| NCT03006952 |
Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy |
https://ClinicalTrials.gov/show/NCT03006952 |
Completed |
Tehran University of Medical Sciences |
2015-09-30 |
| NCT02928250 |
Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT02928250 |
Completed |
Ain Shams University |
2016-05-31 |
| NCT02923063 |
Exercise Study Testing Enhanced Energetics of Muscle Mitochondria in CKD |
https://ClinicalTrials.gov/show/NCT02923063 |
Recruiting |
University of California, Davis |
2021-12-31 |
| NCT02829177 |
Microalbuminuria and Allopurinol in Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT02829177 |
Completed |
Steno Diabetes Center Copenhagen |
2016-08-10 |
| NCT02816762 |
CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea |
https://ClinicalTrials.gov/show/NCT02816762 |
Active, not recruiting |
Hospital Universitario La Paz |
2020-07-31 |
| NCT02768948 |
Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy? |
https://ClinicalTrials.gov/show/NCT02768948 |
Recruiting |
Centre Hospitalier Universitaire de Nice |
2019-07-31 |
| NCT02704494 |
Resveratrol’s Effects in Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT02704494 |
Completed |
Shiraz University of Medical Sciences |
2017-02-28 |
| NCT02690883 |
Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT02690883 |
Completed |
Nanfang Hospital of Southern Medical University |
2019-12-13 |
| NCT02689778 |
Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT02689778 |
Active, not recruiting |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2019-12-31 |
| NCT02676401 |
An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT02676401 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2017-08-31 |
| NCT02628106 |
Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT02628106 |
Completed |
West China Hospital |
2016-01-31 |
| NCT02585622 |
NEPHSTROM for Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT02585622 |
Recruiting |
Mario Negri Institute for Pharmacological Research |
2020-06-30 |
| NCT02682563 |
Renoprotective Effects of Dapagliflozin in Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT02682563 |
Completed |
VU University Medical Center |
2018-09-30 |
| NCT02552277 |
A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy |
https://ClinicalTrials.gov/show/NCT02552277 |
Completed |
Celularity Incorporated |
2017-03-07 |
| NCT02545738 |
Antiproteinuric Effects of Liraglutide Treatment |
https://ClinicalTrials.gov/show/NCT02545738 |
Completed |
Steno Diabetes Center Copenhagen |
2016-05-31 |
| NCT02545049 |
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT02545049 |
Active, not recruiting |
Bayer |
2021-06-21 |
| NCT02540993 |
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT02540993 |
Completed |
Bayer |
2020-04-14 |
| NCT02517320 |
Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT02517320 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2016-11-30 |
| NCT02515461 |
Low Energy Shockwave Therapy (LE-SWT): A Novel Treatment for Chronic Kidney Disease |
https://ClinicalTrials.gov/show/NCT02515461 |
Recruiting |
Odense University Hospital |
2022-01-31 |
| NCT02502071 |
Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT02502071 |
Completed |
University of Colorado Denver School of Medicine Barbara Davis Center |
2017-07-31 |
| NCT02501772 |
The Evaluation of Effect of Sanyinjiao (SP6) Acupressure on Early Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT02501772 |
Recruiting |
Mackay Memorial Hospital |
2015-08-31 |
| NCT02488252 |
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT02488252 |
Active, not recruiting |
The University of Hong Kong |
2020-09-30 |
| NCT02418091 |
Integrated Population Program for Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT02418091 |
Completed |
Duke University |
2016-09-30 |
| NCT02384902 |
Effect of Low GI/ Glycemic Load (GL) Diet in Diabetic Nephropathy Patients |
https://ClinicalTrials.gov/show/NCT02384902 |
Completed |
Isfahan University of Medical Sciences |
2014-07-31 |
| NCT02345057 |
A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria |
https://ClinicalTrials.gov/show/NCT02345057 |
Completed |
Daiichi Sankyo, Inc. |
2016-06-30 |
| NCT02327754 |
Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout |
https://ClinicalTrials.gov/show/NCT02327754 |
Completed |
Sanwa Kagaku Kenkyusho Co., Ltd. |
2016-12-31 |
| NCT02276196 |
Effect of LIXIsenatide on the Renal System |
https://ClinicalTrials.gov/show/NCT02276196 |
Completed |
VU University Medical Center |
2016-04-30 |
| NCT02251067 |
Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients |
https://ClinicalTrials.gov/show/NCT02251067 |
Completed |
Vascular Pharmaceuticals, Inc. |
2017-03-31 |
| NCT02205372 |
Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT02205372 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2015-08-31 |
| NCT02194790 |
Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting. |
https://ClinicalTrials.gov/show/NCT02194790 |
Completed |
Bhumirajanagarindra Kidney Institute, Thailand |
2013-12-31 |
| NCT02177786 |
Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT02177786 |
Completed |
Gilead Sciences |
2016-07-31 |
| NCT02164279 |
Validation of Biomarkers of Diabetic Nephropathy in Type I Diabetic Children |
https://ClinicalTrials.gov/show/NCT02164279 |
Completed |
University Hospital, Toulouse |
2015-12-31 |
| NCT02112071 |
Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function. |
https://ClinicalTrials.gov/show/NCT02112071 |
Completed |
University of Minnesota |
2012-11-30 |
| NCT02065791 |
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT02065791 |
Completed |
Janssen Research & Development, LLC |
2018-10-30 |
| NCT02040441 |
Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria |
https://ClinicalTrials.gov/show/NCT02040441 |
Completed |
Steno Diabetes Center Copenhagen |
2018-11-30 |
| NCT02035891 |
Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria |
https://ClinicalTrials.gov/show/NCT02035891 |
Active, not recruiting |
Chongqing Medical University |
2019-09-30 |
| NCT02017171 |
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT02017171 |
Completed |
Joslin Diabetes Center |
2019-07-15 |
| NCT02010242 |
Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria |
https://ClinicalTrials.gov/show/NCT02010242 |
Completed |
Genkyotex Innovation SAS |
2015-02-28 |
| NCT02004327 |
The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male Volunteer |
https://ClinicalTrials.gov/show/NCT02004327 |
Completed |
Dong Wha Pharmaceutical Co. Ltd. |
2013-12-31 |
| NCT01968668 |
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan) |
https://ClinicalTrials.gov/show/NCT01968668 |
Completed |
Bayer |
2014-10-31 |
| NCT01967901 |
Impact of Multidisciplinary Self-care Management of Diabetic Nephropathy on Quality of Life, Self-care Behavior, Glycemic Control, and Renal Function. |
https://ClinicalTrials.gov/show/NCT01967901 |
Completed |
University of Applied Sciences of Western Switzerland |
2016-02-29 |
| NCT01935167 |
To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01935167 |
Completed |
Dong Wha Pharmaceutical Co. Ltd. |
2014-08-31 |
| NCT01923597 |
Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy. |
https://ClinicalTrials.gov/show/NCT01923597 |
Completed |
University of Campinas, Brazil |
2015-03-31 |
| NCT01889277 |
Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01889277 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2015-01-31 |
| NCT01875341 |
Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients. |
https://ClinicalTrials.gov/show/NCT01875341 |
Completed |
Ottawa Hospital Research Institute |
2015-02-28 |
| NCT01874431 |
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01874431 |
Completed |
Bayer |
2014-07-31 |
| NCT01847313 |
The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT01847313 |
Completed |
University College Dublin |
2015-11-30 |
| NCT01843387 |
Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01843387 |
Completed |
Mesoblast, Ltd. |
2014-09-30 |
| NCT01829256 |
Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) |
https://ClinicalTrials.gov/show/NCT01829256 |
Completed |
Duke University |
2018-11-07 |
| NCT01774981 |
Study of LY3016859 in Participants With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01774981 |
Completed |
Eli Lilly and Company |
2015-08-31 |
| NCT01756716 |
A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR |
https://ClinicalTrials.gov/show/NCT01756716 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2014-09-30 |
| NCT01756703 |
A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria |
https://ClinicalTrials.gov/show/NCT01756703 |
Completed |
Mitsubishi Tanabe Pharma Corporation |
2014-08-31 |
| NCT01726816 |
Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01726816 |
Completed |
Korea Otsuka Pharmaceutical Co., Ltd. |
2014-04-30 |
| NCT01712061 |
A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy |
https://ClinicalTrials.gov/show/NCT01712061 |
Completed |
Pfizer |
2014-09-30 |
| NCT01703234 |
FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients |
https://ClinicalTrials.gov/show/NCT01703234 |
Completed |
Gulhane School of Medicine |
2009-03-31 |
| NCT01684722 |
Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT01684722 |
Completed |
University of Washington |
2019-11-08 |
| NCT01683409 |
A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT01683409 |
Completed |
Eli Lilly and Company |
2014-09-30 |
| NCT01671969 |
Very Low Calorie Diet for Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT01671969 |
Completed |
Indiana University |
2014-03-31 |
| NCT01601236 |
Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients |
https://ClinicalTrials.gov/show/NCT01601236 |
Completed |
Mallinckrodt |
2016-01-31 |
| NCT01588795 |
Renal Denervation in Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01588795 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2016-01-31 |
| NCT01521910 |
Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01521910 |
Completed |
Steno Diabetes Center Copenhagen |
2000-06-30 |
| NCT01493050 |
The Effects of Sevelamer Carbonate on Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01493050 |
Completed |
Icahn School of Medicine at Mount Sinai |
2013-12-31 |
| NCT01487109 |
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients |
https://ClinicalTrials.gov/show/NCT01487109 |
Completed |
Concert Pharmaceuticals |
2015-01-31 |
| NCT01447147 |
A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01447147 |
Completed |
ChemoCentryx |
2014-08-31 |
| NCT01440257 |
A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria |
https://ClinicalTrials.gov/show/NCT01440257 |
Completed |
ChemoCentryx |
2013-02-28 |
| NCT01424319 |
Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan |
https://ClinicalTrials.gov/show/NCT01424319 |
Completed |
AbbVie |
2012-07-31 |
| NCT01399580 |
A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With Nephropathy |
https://ClinicalTrials.gov/show/NCT01399580 |
Completed |
AbbVie |
2012-09-30 |
| NCT01371747 |
Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN) |
https://ClinicalTrials.gov/show/NCT01371747 |
Completed |
Relypsa, Inc. |
2013-05-31 |
| NCT01356849 |
Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor |
https://ClinicalTrials.gov/show/NCT01356849 |
Completed |
AbbVie |
2012-08-31 |
| NCT01331317 |
Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01331317 |
Completed |
Steno Diabetes Center Copenhagen |
2012-04-30 |
| NCT01328821 |
Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499 |
https://ClinicalTrials.gov/show/NCT01328821 |
Completed |
Concert Pharmaceuticals |
2011-04-30 |
| NCT01320345 |
The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. |
https://ClinicalTrials.gov/show/NCT01320345 |
Recruiting |
University of Sydney |
2022-01-31 |
| NCT04224428 |
Role of Fexofenadine in Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT04224428 |
Recruiting |
Tanta University |
2020-07-01 |
| NCT04216849 |
Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT04216849 |
Recruiting |
Shanghai East Hospital |
2021-11-01 |
| NCT04170543 |
A Phase 2a Diabetic Kidney Disease Study |
https://ClinicalTrials.gov/show/NCT04170543 |
Active, not recruiting |
AstraZeneca |
2021-10-04 |
| NCT04143412 |
Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination |
https://ClinicalTrials.gov/show/NCT04143412 |
Recruiting |
Beni-Suef University |
2020-02-29 |
| NCT04127084 |
Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT04127084 |
Recruiting |
Zhongshan Hospital Xiamen University |
2020-10-31 |
| NCT04026165 |
Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT04026165 |
Active, not recruiting |
Gilead Sciences |
2024-12-31 |
| NCT03965975 |
Clinical Validation Through Analytical Study With Urine Samples to Compare the Effectiveness and Security of an Intelligent Device |
https://ClinicalTrials.gov/show/NCT03965975 |
Recruiting |
S-There Technologies SL |
2020-03-31 |
| NCT03899883 |
Uric Acid Lowering Trial in Youth Onset T2D |
https://ClinicalTrials.gov/show/NCT03899883 |
Recruiting |
University of Colorado Denver School of Medicine Barbara Davis Center |
2020-05-31 |
| NCT03885362 |
Assessment of the Accuracy of Continuous Glucose Sensors in People With Diabetes Undergoing Haemodialysis |
https://ClinicalTrials.gov/show/NCT03885362 |
Recruiting |
Imperial College London |
2020-09-30 |
| NCT03878277 |
Evaluation of Coffee Therapy for Improvement of Renal Oxygenation |
https://ClinicalTrials.gov/show/NCT03878277 |
Active, not recruiting |
University of Colorado Denver School of Medicine Barbara Davis Center |
2020-01-21 |
| NCT03840343 |
Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT03840343 |
Recruiting |
Mayo Clinic |
2024-12-31 |
| NCT03804879 |
Safety, Tolerability and Efficacy of LMB763 in Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT03804879 |
Recruiting |
Novartis |
2021-12-16 |
| NCT03681704 |
the Integrated Traditional Chinese and Western Medicine Treat Early Stage DKD |
https://ClinicalTrials.gov/show/NCT03681704 |
Recruiting |
Shanghai University of Traditional Chinese Medicine |
2021-09-30 |
| NCT03681249 |
the Integrated Traditional Chinese and Western Medicine Treat Middle Stage DKD |
https://ClinicalTrials.gov/show/NCT03681249 |
Recruiting |
Shanghai University of Traditional Chinese Medicine |
2021-09-30 |
| NCT03664414 |
Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY) |
https://ClinicalTrials.gov/show/NCT03664414 |
Recruiting |
Coordinación de Investigación en Salud, Mexico |
2019-07-30 |
| NCT03627715 |
Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan |
https://ClinicalTrials.gov/show/NCT03627715 |
Active, not recruiting |
Dimerix Bioscience Pty Ltd |
2020-07-31 |
| NCT03625648 |
Pentoxifylline in Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT03625648 |
Active, not recruiting |
VA Office of Research and Development |
2028-01-03 |
| NCT03622762 |
Green Tea Extract on Soluble RAGE in Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT03622762 |
Recruiting |
Centro Universitario de Ciencias de la Salud, Mexico |
2019-03-15 |
| NCT03620773 |
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT03620773 |
Recruiting |
University of Colorado Denver School of Medicine Barbara Davis Center |
2023-08-31 |
| NCT03618420 |
Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function |
https://ClinicalTrials.gov/show/NCT03618420 |
Active, not recruiting |
University of Colorado Denver School of Medicine Barbara Davis Center |
2019-10-19 |
| NCT03594240 |
Vitamin B Complex and Diabetic Nephropathy in Type 1 Diabetes |
https://ClinicalTrials.gov/show/NCT03594240 |
Completed |
Ain Shams University |
2018-03-01 |
| NCT03573102 |
Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients |
https://ClinicalTrials.gov/show/NCT03573102 |
Recruiting |
Ain Shams University |
2020-06-30 |
| NCT03550443 |
A Phase 3 Study of Bardoxolone Methyl in Patients With Diabetic Kidney Disease; AYAME Study |
https://ClinicalTrials.gov/show/NCT03550443 |
Active, not recruiting |
Kyowa Kirin Co., Ltd. |
2022-03-31 |
| NCT03535935 |
Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT03535935 |
Recruiting |
The University of Hong Kong |
2022-06-30 |
| NCT03449199 |
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria |
https://ClinicalTrials.gov/show/NCT03449199 |
Completed |
Teijin America, Inc. |
2019-05-07 |
| NCT03445247 |
Extracorporeal Low-intensity Shockwave in Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT03445247 |
Recruiting |
Chang Gung Memorial Hospital |
2019-06-30 |
| NCT03436693 |
Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT03436693 |
Active, not recruiting |
Mitsubishi Tanabe Pharma Corporation |
2021-09-30 |
| NCT03413215 |
Effects of Multidisciplinary Intensive Targeted Care in Improving Diabetes Outcomes: a Pilot Study in Singapore |
https://ClinicalTrials.gov/show/NCT03413215 |
Recruiting |
Changi General Hospital |
2021-12-31 |
| NCT03412006 |
A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT03412006 |
Completed |
Bayer |
2019-10-02 |
| NCT01265563 |
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01265563 |
Completed |
VA Office of Research and Development |
2015-02-28 |
| NCT01252056 |
A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01252056 |
Completed |
Otsuka Beijing Research Institute |
2012-12-31 |
| NCT01214356 |
Impact of Vitamin D on Diabetic Kidney Disease in African Americans |
https://ClinicalTrials.gov/show/NCT01214356 |
Completed |
Medical University of South Carolina |
2013-07-31 |
| NCT01200394 |
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy |
https://ClinicalTrials.gov/show/NCT01200394 |
Completed |
Pfizer |
2013-07-31 |
| NCT01191983 |
A Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) for the Treatment of Chronic Renal Anemia in Participants With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01191983 |
Completed |
Hoffmann-La Roche |
2018-04-23 |
| NCT01130727 |
The Effect of Green Tea or Cocoa Extracts in Endothelial Dysfunction in Patients With Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT01130727 |
Completed |
University of Campinas, Brazil |
2012-02-29 |
| NCT01109212 |
The Effects of Bindarit in Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01109212 |
Completed |
Aziende Chimiche Riunite Angelini Francesco S.p.A |
2008-11-30 |
| NCT01068041 |
Effects of PH3 in Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01068041 |
Completed |
PhytoHealth Corporation |
2014-07-31 |
| NCT01028287 |
Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN) |
https://ClinicalTrials.gov/show/NCT01028287 |
Completed |
Southeast Renal Research Institute |
2010-12-31 |
| NCT01015937 |
Effect of Turmeric on Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01015937 |
Completed |
Shaheed Faghihi Hospital |
2009-06-30 |
| NCT01003236 |
Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT01003236 |
Completed |
Shiraz University of Medical Sciences |
2011-10-31 |
| NCT00967629 |
Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00967629 |
Completed |
Icahn School of Medicine at Mount Sinai |
2010-02-28 |
| NCT00920764 |
A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors |
https://ClinicalTrials.gov/show/NCT00920764 |
Completed |
AbbVie |
2010-04-30 |
| NCT00915200 |
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00915200 |
Completed |
The University of Texas Health Science Center at San Antonio |
2016-04-30 |
| NCT00914524 |
Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00914524 |
Completed |
Daiichi Sankyo, Inc. |
2006-04-30 |
| NCT00893425 |
Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria |
https://ClinicalTrials.gov/show/NCT00893425 |
Completed |
Gulhane School of Medicine |
2009-03-31 |
| NCT03869931 |
Effects of Fenofibrate Therapy in Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT03869931 |
Recruiting |
Singapore General Hospital |
2021-04-30 |
| NCT00811889 |
Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease |
https://ClinicalTrials.gov/show/NCT00811889 |
Completed |
Reata Pharmaceuticals, Inc. |
2010-05-31 |
| NCT01667614 |
Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure |
https://ClinicalTrials.gov/show/NCT01667614 |
Completed |
Tehran University of Medical Sciences |
2012-03-31 |
| NCT02914691 |
Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT02914691 |
Completed |
Steno Diabetes Center Copenhagen |
2017-07-05 |
| NCT02509624 |
Pharmacokinetics of GS-4997 in Adults With Normal and Impaired Hepatic Function |
https://ClinicalTrials.gov/show/NCT02509624 |
Completed |
Gilead Sciences |
2015-12-31 |
| NCT03889236 |
Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy. |
https://ClinicalTrials.gov/show/NCT03889236 |
Recruiting |
Leiden University Medical Center |
2019-12-31 |
| NCT03415074 |
Could Ketoanalogue-supplemented Low Protein Diet Defer Dialysis in Advanced Diabetic Kidney Disease? (K-DDD) |
https://ClinicalTrials.gov/show/NCT03415074 |
Recruiting |
Anemia Working Group Romania |
2022-09-30 |
| NCT00782847 |
Evaluation Study for the Programme DiaNe for People With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00782847 |
Completed |
DiaNe HCM GmbH |
2007-01-31 |
| NCT00774904 |
Adiponectin and Insulin Resistance in Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00774904 |
Completed |
Health Science Center of Xi’an Jiaotong University |
2007-10-31 |
| NCT00754143 |
Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00754143 |
Completed |
FibroGen |
2009-12-31 |
| NCT00738660 |
Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy |
https://ClinicalTrials.gov/show/NCT00738660 |
Completed |
Postgraduate Institute of Medical Education and Research |
2008-05-31 |
| NCT00737126 |
The Effect of Folic Acid Administration in the Progression of Microalbuminuria |
https://ClinicalTrials.gov/show/NCT00737126 |
Completed |
Hospital Universitario Dr. Jose E. Gonzalez |
2005-12-31 |
| NCT00734253 |
Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT00734253 |
Completed |
NephroGenex, Inc. |
2010-08-31 |
| NCT00708981 |
Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN) |
https://ClinicalTrials.gov/show/NCT00708981 |
Completed |
John H. Stroger Hospital |
2013-10-31 |
| NCT00663949 |
Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00663949 |
Completed |
Shiraz University of Medical Sciences |
2007-12-31 |
| NCT00664027 |
Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00664027 |
Completed |
Reata Pharmaceuticals, Inc. |
2009-05-31 |
| NCT00594152 |
Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT) |
https://ClinicalTrials.gov/show/NCT00594152 |
Completed |
Joslin Diabetes Center |
NA |
| NCT00565318 |
Benfotiamine in Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00565318 |
Completed |
University Medical Center Groningen |
2009-06-30 |
| NCT00561704 |
Adiponectin in Obese Women With T2DN and Effects by RAS Blocker |
https://ClinicalTrials.gov/show/NCT00561704 |
Completed |
Shanghai Jiao Tong University School of Medicine |
NA |
| NCT00556465 |
Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00556465 |
Completed |
Shiraz University of Medical Sciences |
NA |
| NCT00552409 |
Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT00552409 |
Completed |
University of Washington |
2010-06-30 |
| NCT00544934 |
Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects |
https://ClinicalTrials.gov/show/NCT00544934 |
Completed |
Glycadia |
NA |
| NCT00535925 |
Nephropathy In Type 2 Diabetes and Cardio-renal Events |
https://ClinicalTrials.gov/show/NCT00535925 |
Completed |
University of Campania “Luigi Vanvitelli” |
2011-12-31 |
| NCT00518362 |
To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN) |
https://ClinicalTrials.gov/show/NCT00518362 |
Completed |
Nanjing University School of Medicine |
2009-09-30 |
| NCT00498537 |
Spironolactone for Reducing Proteinuria in Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00498537 |
Completed |
VA Office of Research and Development |
2005-12-31 |
| NCT00484068 |
Chicken-Diet vs. Enalapril to Reduce Albuminuria |
https://ClinicalTrials.gov/show/NCT00484068 |
Completed |
Hospital de Clinicas de Porto Alegre |
NA |
| NCT00464880 |
Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00464880 |
Completed |
Novartis |
NA |
| NCT00446459 |
Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant. |
https://ClinicalTrials.gov/show/NCT00446459 |
Completed |
University of Washington |
2008-11-30 |
| NCT00446251 |
Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant |
https://ClinicalTrials.gov/show/NCT00446251 |
Completed |
University of Washington |
2008-04-30 |
| NCT00438503 |
Glucose in Dialysis Water in Diabetics With Chronic Renal Failure |
https://ClinicalTrials.gov/show/NCT00438503 |
Completed |
Regional Hospital Holstebro |
NA |
| NCT00421733 |
The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors |
https://ClinicalTrials.gov/show/NCT00421733 |
Completed |
Abbott |
2009-06-30 |
| NCT00419835 |
Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT00419835 |
Completed |
University of Sao Paulo |
2007-09-30 |
| NCT00364988 |
Pioglitazone and Losartan Provides Additional Renoprotection |
https://ClinicalTrials.gov/show/NCT00364988 |
Completed |
Shanghai Jiao Tong University School of Medicine |
2005-12-31 |
| NCT00363987 |
Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN) |
https://ClinicalTrials.gov/show/NCT00363987 |
Completed |
Fresenius Kabi |
2008-12-31 |
| NCT00362960 |
Olmesartan Medoxomil and Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00362960 |
Completed |
Daiichi Sankyo, Inc. |
NA |
| NCT00361023 |
Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy |
https://ClinicalTrials.gov/show/NCT00361023 |
Completed |
Shanghai Jiao Tong University School of Medicine |
NA |
| NCT00354341 |
(ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00354341 |
Completed |
Hoffmann-La Roche |
2005-07-31 |
| NCT00340678 |
Renoprotection in Early Diabetic Nephropathy in Pima Indians |
https://ClinicalTrials.gov/show/NCT00340678 |
Completed |
National Institutes of Health Clinical Center (CC) |
2012-05-31 |
| NCT00324675 |
Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00324675 |
Completed |
Technische Universität Dresden |
2008-12-31 |
| NCT00320970 |
Angiotensin II Antagonism of TGF-Beta 1 |
https://ClinicalTrials.gov/show/NCT00320970 |
Completed |
Providence Health & Services |
NA |
| NCT00320060 |
Effect of Pyridorin in Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00320060 |
Completed |
BioStratum |
NA |
| NCT00320021 |
Effect of Pyridorin in Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00320021 |
Completed |
BioStratum |
NA |
| NCT00317954 |
Spironolactone in Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00317954 |
Completed |
Steno Diabetes Center Copenhagen |
NA |
| NCT00315016 |
Eplerenone, ACE Inhibition and Albuminuria |
https://ClinicalTrials.gov/show/NCT00315016 |
Completed |
Radboud University |
2011-07-31 |
| NCT00312780 |
Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00312780 |
Completed |
Symphony Evolution, Inc. |
2007-10-31 |
| NCT00311870 |
Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00311870 |
Completed |
Steno Diabetes Center Copenhagen |
NA |
| NCT00296296 |
Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) |
https://ClinicalTrials.gov/show/NCT00296296 |
Completed |
Stanford University |
2014-10-31 |
| NCT00295555 |
Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00295555 |
Completed |
Yokohama City University Medical Center |
NA |
| NCT00287183 |
6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria |
https://ClinicalTrials.gov/show/NCT00287183 |
Completed |
Pfizer |
2009-08-31 |
| NCT00272831 |
The Use of Cilostazol in Patients With Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00272831 |
Completed |
Chinese University of Hong Kong |
2007-12-31 |
| NCT00253786 |
Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00253786 |
Completed |
Okayama University |
2014-11-27 |
| NCT00240019 |
Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease. |
https://ClinicalTrials.gov/show/NCT00240019 |
Completed |
Stanford University |
NA |
| NCT00237952 |
Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00237952 |
Completed |
Chang Gung Memorial Hospital |
NA |
| NCT00222846 |
Enhancing Adherence in Type 2 Diabetes: The ENHANCE Study |
https://ClinicalTrials.gov/show/NCT00222846 |
Completed |
University of Pittsburgh |
2009-12-31 |
| NCT00212901 |
High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy |
https://ClinicalTrials.gov/show/NCT00212901 |
Completed |
Ottawa Hospital Research Institute |
NA |
| NCT00171574 |
Antiproteinuric Effect of Valsartan and Lisinopril |
https://ClinicalTrials.gov/show/NCT00171574 |
Completed |
Novartis |
2006-07-31 |
| NCT00168857 |
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) |
https://ClinicalTrials.gov/show/NCT00168857 |
Completed |
Boehringer Ingelheim |
2006-06-30 |
| NCT00153088 |
INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00153088 |
Completed |
Boehringer Ingelheim |
2005-11-30 |
| NCT00153023 |
1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy |
https://ClinicalTrials.gov/show/NCT00153023 |
Completed |
Boehringer Ingelheim |
2005-12-31 |
| NCT00141453 |
ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial |
https://ClinicalTrials.gov/show/NCT00141453 |
Completed |
Daiichi Sankyo, Inc. |
2008-08-31 |
| NCT00136188 |
Nitric Oxide (NO) Activity and Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00136188 |
Completed |
University of Erlangen-Nürnberg Medical School |
2011-12-31 |
| NCT00130208 |
Effect of Sulodexide in Early Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00130208 |
Completed |
Keryx Biopharmaceuticals |
2008-01-31 |
| NCT00118976 |
Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease |
https://ClinicalTrials.gov/show/NCT00118976 |
Completed |
Steno Diabetes Center Copenhagen |
NA |
| NCT00106561 |
Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney |
https://ClinicalTrials.gov/show/NCT00106561 |
Completed |
Melbourne Health |
NA |
| NCT00097955 |
Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria |
https://ClinicalTrials.gov/show/NCT00097955 |
Completed |
Novartis |
2007-04-30 |
| NCT00067678 |
Soy Protein in Early Diabetic Nephropathy |
https://ClinicalTrials.gov/show/NCT00067678 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
NA |
| NCT00063583 |
Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes |
https://ClinicalTrials.gov/show/NCT00063583 |
Completed |
Sharma, Kumar, M.D. |
2007-11-30 |
| NCT00044148 |
The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT00044148 |
Completed |
Chromaderm, Inc. |
2004-04-28 |
| NCT00004266 |
Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT00004266 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
1999-07-31 |